Histopathologic Classification of Liver Pathologies

Total Page:16

File Type:pdf, Size:1020Kb

Histopathologic Classification of Liver Pathologies 2 Histopathologic Classification of Liver Pathologies CONTENTS 2.8.3 Fatty Liver 2.8.4 Wilson’s Disease 2.1 Benign and Malignant Nodular Hepatocellular 2.8.5 Primary Sclerosing Cholangitis Lesions 2.8.6 Cirrhosis 2.1.1 Regenerative Lesions 2.8.7 Primary Biliary Cirrhosis 2.1.2 Dysplastic or Neoplastic Lesions 2.8.8 Secondary Biliary Cirrhosis 2.2 Benign and Malignant Tumors of the Biliary 2.8.9 Reye’s Syndrome Tract 2.8.10 Caroli’s Syndrome 2.2.1 Bile Duct Adenoma 2.8.11 Liver Disease in Patients with Cystic Kidneys 2.2.2 Bile Duct Cystadenoma 2.8.12 Langerhans Cell Histiocytosis 2.2.3 Biliary Papillomatosis 2.8.13 Storage Diseases 2.2.4 Bile Duct Carcinoma (Cholangiocarcinoma) 2.8.14 Viral Hepatitis 2.2.5 Bile Duct Cystadenocarcinoma 2.8.15 Liver Disease in Congestive Heart Disease 2.2.6 Gallbladder Carcinoma 2.9 Vascular Changes 2.3 Benign Non-Epithelial Tumors 2.9.1 Thrombosis of the Portal Vein 2.3.1 Hemangioma 2.9.2 Obstruction of Smaller Portal Branches 2.3.2 Infantile Hemangioendothelioma 2.9.3 Budd-Chiari Syndrome 2.3.3 Lymphangioma 2.9.4 Veno-Occlusive Disease 2.3.4 Angiomyolipoma 2.9.5 Lobular or Segmental Atrophy 2.4 Malignant Non-Epithelial Tumors 2.9.6 Infarction / Ischemia 2.4.1 Angiosarcoma 2.1 0 HIV-associated Liver Diseases 2.4.2 Malignant Epitheloid Hemangioendothelioma 2.10.1 Kaposi’s Sarcoma 2.4.3 Undifferentiated (Embryonal) Sarcoma 2.10.2 Primary Lymphoma of the Liver 2.4.4 Rhabdomyosarcoma (Sarcoma Botryoides) 2.10.3 Cholangitis 2.4.5 Other Primary Sarcomas 2.10.4 Fungal Infections 2.4.6 Primary Lymphoma of the Liver 2.10.5 Protozoal Infections 2.5 Hepatoblastoma 2.10.6 Bacterial Infections 2.6 Tumor-like Lesions 2.1 1 Hepatic Trauma 2.6.1 Cysts 2.1 2 Metastases 2.6.2 Mesenchymal Hamartoma 2.12.1 Metastases of Colorectal Adenocarcinoma 2.6.3 Biliary Hamartoma 2.12.2 Metastases of Breast Carcinoma 2.6.4 Inflammatory Pseudotumor 2.12.3 Carcinoid Metastases 2.6.5 Other Tumor-like Lesions: Peliosis Hepatis 2.1 3 Infiltration of the Liver in Hematologic 2.7 Infectious Diseases of the Liver Diseases 2.7.1 Liver Abscess 2.13.1 Non-Hodgkin’s Lymphoma 2.7.2 Helminthic Infections 2.13.2 Hepatic Hodgkin’s Lymphoma 2.8 Parenchymal Disease 2.8.1 Hemochromatosis 2.8.2 Transfusional Iron Overload (Hemosiderosis) 18 MRI of the Liver 2.1 Benign and Malignant Nodular Hepatocellular Lesions 2.1.1 Regenerative Lesions Generally, a regenerative nodule is a well-circum- scribed area of parenchyma showing enlargement as a response to necrosis, altered circulation or other stimuli. Fig. 1. Cut surface of a nodular regenerative hyperplasia (NRH) 2.1.1.1 Monoacinar Regenerative Nodule A monoacinar regenerative nodule is a regenera- tive nodule limited to one portal tract. Usually, multiple nodules are found involving most of the liver. This is referred to as diffuse nodular hyper- plasia [184]. Diffuse Nodular Hyperplasia without Fibrous Septa (Nodular Regenerative Hyperplasia, NRH) Diffuse nodular hyperplasia can be subdivided in- to nodular regenerative hyperplasia in which no fi- brous septa can be found, or diffuse nodular hy- perplasia containing fibrous septa or occuring in coexisting cirrhosis. Nodular hyperplasia is defined by the presence Fig. 2. Nodular regenerative hyperplasia demonstrating a non- of non-neoplastic nodules that are not limited by neoplastic nodule with hyperplastic liver cells surrounded by at- fibrous septa (Fig. 1). The cells of the surrounding rophic parenchyma parenchyma are atrophic (Fig. 2). Nodular hyper- plasia is usually a regenerative response occurring after circulatory stress. Portal vein obstruction may be responsible for widespread hepatocellular atrophy and secondary hepatic arterial dilatation (Fig. 3). Increased arterial flow and possible hepa- totropic factors cause hepatocellular hyperplasia and nodule formation. Monoacinar regenerative nodules may also occur in cases of disturbed circulation, such as hepatic vein obstruction and circulation disor- ders of the sinusoids. However, the resulting nodules are less uniformly distributed and are accompanied by more congestion and fibrous septa. The term NRH was originally applied to livers with minimal or no parenchymal fibrosis. NRH can be found in up to 5% of the older population. A higher prevalence occurs in patients with con- comitant systemic diseases associated with vascu- Fig. 3. Histology of diffuse nodular regenerative hyperplasia with lopathy, such as polycythemia, rheumatoid arthri- demonstration of multiple nodules (arrows) surrounded by atro- tis and polyarteritis nodosa. phy in adjacent liver tissue caused by Budd-Chiari syndrome 2 • Histopathologic Classification of Liver Pathologies 19 Clinical symptoms, which aid the diagnosis in affected patients, include esophageal varices, splenomegaly, moderate increased alkaline phos- phatase and ascites [118, 176]. Diffuse Nodular Hyperplasia with Fibrous Septa or in Cirrhosis As described above, this lesion corresponds to nodular regenerative hyperplasia with concomi- tant fibrous septa, or which is superimposed on a previous hepatic cirrhosis [177, 184]. Fig. 4 . Nodular regenerative hyperplasia with a diffuse micro- nodular pattern 2.1.1.2 Multiacinar Regenerative Nodule 2.1.1.4 Cirrhotic Nodule (Monoacinar Cirrhotic Nodule/ A regenerative nodule involving more than one Multiacinar Cirrhotic Nodule) solitary portal tract is called a multiacinar regen- erative nodule. Normally, it presents in livers with Generally, a cirrhotic nodule is defined as a regen- pre-existing pathology such as cirrhosis, or in cas- erative nodule in which hepatocytes are partially es of severe disease of the portal veins, hepatic or completely surrounded by fibrous septa. It can veins, or sinusoids. Usually, multiple nodules oc- be subdivided according to its expansion. Thus, a cur within the liver and these can correspond to monoacinar cirrhotic nodule contains no more cirrhotic nodules if they are surrounded by fibrous than one terminal portal tract, whereas a multiaci- septa. If larger than most cirrhotic nodules of the nar cirrhotic nodule is composed of two or more same liver or measuring at least 5 mm in diameter, portal tracts. However, this definition is not in ac- multiacinar regenerative nodules are also called cordance with the classifications micronodule and large regenerative nodules or macroregenerative macronodule that exist in cirrhosis. This is usually nodules [172] (Fig. 4). defined by size with a division point at 3 mm in di- ameter [14]. 2.1.1.3 2.1.1.5 Lobar or Segmental Hyperplasia Focal Nodular Hyperplasia (FNH) Lobar or segmental hyperplasia is defined as the Focal nodular hyperplasia is defined as a nodule enlargement of an entire lobe or the major part of that consists of benign-appearing hepatocytes a lobe in one or several liver segments, while other which are accompanied by fibrous stroma and parts of the liver show atrophy, necrosis or fibrosis. which may contain ductules that form a character- This pathologic pattern has also been described as istic central stellate scar. It usually occurs in an atrophy-hypertrophy complex [71]. otherwise histologically normal or nearly normal Lobar or segmental hyperplasia may occur in liver. Budd-Chiari syndrome or in primary sclerosing Similar to adenoma (2.1.2.1), FNH is predomi- cholangitis involving the hepatic veins or bile nantly found in female patients. Although oral ducts. It introduces both a hyperplasia and an contraception does not seem to be causal, continu- atrophy or fibrosis into the liver parenchyma. As ous enlargement of lesions has been reported con- hyperplasia typically arises in regions with in- comitant with the taking of birth-control pills and creased blood flow in Budd-Chiari syndrome, during pregnancy [182]. the caudate lobe often presents as hyperplastic Multiple FNH occur in 10-20% of all cases because the drainage of this part of the liver is while an association with hemangioma occurs in usually independent of the main hepatic veins. 5-10% of cases [78, 107]. Normally lobar or segmental hyperplasia meas- Macroscopically, FNH shows septations and, in ures at least several centimeters in diameter but classical cases, a central scar. However, in up to consists of histologically normal liver cells 30% of all cases a central scar is not present. In [164]. contrast to fibrolamellar carcinoma (2.1.2.5), the 20 MRI of the Liver Fig. 5. Focal nodular hyperplasia consists of liver nodules which Fig. 6. Histology of focal nodular hyperplasia demonstrating are separated by fibrous septa (arrows). Bile ducts, sometimes nu- Kupffer cells (arrows) merous, are always present at the interface between liver nodules and septa. scar is not a true one, but rather congeries of blood often resembles adenoma. The teleangiectatic type vessels and bile ducts and sometimes a focal area presents with atrophic hepatic plates separated by of cirrhosis.An elevated fat- and glycogen-content dilated sinusoids. Short fibrous septa and bile-duct can often be demonstrated. FNH is thought to de- proliferation is always found in teleangiectatic FNH. rive from an initial regional vascular arterio- FNH with cytologic atypia typically exhibit the venous (AV) malformation which undergoes con- appearance of classic FNH, but contain areas of secutive localized overgrowth of all liver con- cell dysplasia. stituents. Thus, histologically, FNH consists of ab- Mixed hyperplastic and adenomatous FNH normally arranged normal liver cells (Fig. 5). In presents features of the teleangiectatic type as well contrast to adenoma, small bile ductules that do as a resemblance to adenoma. not communicate with larger bile ducts are found. A so-called FNH syndrome is present if more Kupffer cells are also present although their func- than two FNH co-exist with intracerebral vascular tion is frequently deficient (Fig. 6). malformations, meningioma or astrocytoma. If FNH is currently divided into a classic and a any of the associated lesions are found in the pres- non-classic type.
Recommended publications
  • Educational Paper Ciliopathies
    Eur J Pediatr (2012) 171:1285–1300 DOI 10.1007/s00431-011-1553-z REVIEW Educational paper Ciliopathies Carsten Bergmann Received: 11 June 2011 /Accepted: 3 August 2011 /Published online: 7 September 2011 # The Author(s) 2011. This article is published with open access at Springerlink.com Abstract Cilia are antenna-like organelles found on the (NPHP) . Ivemark syndrome . Meckel syndrome (MKS) . surface of most cells. They transduce molecular signals Joubert syndrome (JBTS) . Bardet–Biedl syndrome (BBS) . and facilitate interactions between cells and their Alstrom syndrome . Short-rib polydactyly syndromes . environment. Ciliary dysfunction has been shown to Jeune syndrome (ATD) . Ellis-van Crefeld syndrome (EVC) . underlie a broad range of overlapping, clinically and Sensenbrenner syndrome . Primary ciliary dyskinesia genetically heterogeneous phenotypes, collectively (Kartagener syndrome) . von Hippel-Lindau (VHL) . termed ciliopathies. Literally, all organs can be affected. Tuberous sclerosis (TSC) . Oligogenic inheritance . Modifier. Frequent cilia-related manifestations are (poly)cystic Mutational load kidney disease, retinal degeneration, situs inversus, cardiac defects, polydactyly, other skeletal abnormalities, and defects of the central and peripheral nervous Introduction system, occurring either isolated or as part of syn- dromes. Characterization of ciliopathies and the decisive Defective cellular organelles such as mitochondria, perox- role of primary cilia in signal transduction and cell isomes, and lysosomes are well-known
    [Show full text]
  • In Partial Fulfilment of Requirements for the Degree Of
    THE EFFECTS OF FEED-BORNE FUSARIUM MYCOTOXINS ON THE PERFORMANCE AND HEALTH OF RAINBOW TROUT (ONCORHYNCHUS MYKISS) A Thesis Presented to The Faculty of Graduate Studies of The University of Guelph by JAMIE MARIE HOOFT In partial fulfilment of requirements for the degree of Master of Science May, 2010 © Jamie M. Hooft, 2010 Library and Archives Bibliothèque et 1*1 Canada Archives Canada Published Heritage Direction du Branch Patrimoine de l'édition 395 Wellington Street 395, rue Wellington Ottawa ON K1A 0N4 Ottawa ON K1A 0N4 Canada Canada Your file Votre référence ISBN: 978-0-494-67487-1 Our file Notre référence ISBN: 978-0-494-67487-1 NOTICE: AVIS: The author has granted a non- L'auteur a accordé une licence non exclusive exclusive license allowing Library and permettant à la Bibliothèque et Archives Archives Canada to reproduce, Canada de reproduire, publier, archiver, publish, archive, preserve, conserve, sauvegarder, conserver, transmettre au public communicate to the public by par télécommunication ou par l'Internet, prêter, telecommunication or on the Internet, distribuer et vendre des thèses partout dans le loan, distribute and sell theses monde, à des fins commerciales ou autres, sur worldwide, for commercial or non- support microforme, papier, électronique et/ou commercial purposes, in microform, autres formats. paper, electronic and/or any other formats. The author retains copyright L'auteur conserve la propriété du droit d'auteur ownership and moral rights in this et des droits moraux qui protège cette thèse. Ni thesis. Neither the thesis nor la thèse ni des extraits substantiels de celle-ci substantial extracts from it may be ne doivent être imprimés ou autrement printed or otherwise reproduced reproduits sans son autorisation.
    [Show full text]
  • Research Day 2021 Program
    Western Michigan University ScholarWorks at WMU Research Day WMU Homer Stryker M.D. School of Medicine 2021 Research Day 2021 Program Western Michigan University Homer Stryker M.D. School of Medicine Follow this and additional works at: https://scholarworks.wmich.edu/medicine_research_day Part of the Life Sciences Commons, and the Medicine and Health Sciences Commons WMU ScholarWorks Citation Homer Stryker M.D. School of Medicine, Western Michigan University, "Research Day 2021 Program" (2021). Research Day. 298. https://scholarworks.wmich.edu/medicine_research_day/298 This Abstract is brought to you for free and open access by the WMU Homer Stryker M.D. School of Medicine at ScholarWorks at WMU. It has been accepted for inclusion in Research Day by an authorized administrator of ScholarWorks at WMU. For more information, please contact [email protected]. th 38 Annual Kalamazoo Community Medical and Health Sciences Virtual Research Day Wednesday, April 21, 2021 8:00 a.m. – 12:00 p.m. TABLE OF CONTENTS INTRODUCTION ........................................................................................................... 4 KEYNOTE SPEAKER.................................................................................................... 6 SCHEDULE ..................................................................................................................... 7 ORAL PRESENTATIONS ............................................................................................. 8 ORAL ABSTRACTS ....................................................................................................
    [Show full text]
  • ARPKD): Kidney-Related and Non-Kidney-Related Phenotypes
    Pediatr Nephrol (2014) 29:1915–1925 DOI 10.1007/s00467-013-2634-1 EDUCATIONAL REVIEW Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes Rainer Büscher & Anja K. Büscher & Stefanie Weber & Julia Mohr & Bianca Hegen & Udo Vester & Peter F. Hoyer Received: 26 April 2013 /Revised: 5 September 2013 /Accepted: 6 September 2013 /Published online: 10 October 2013 # IPNA 2013 Abstract Autosomal recessive polycystic kidney disease disease. In this review we focus on common and uncommon (ARPKD), although less frequent than the dominant form, is kidney-related and non-kidney-related phenotypes. Clinical a common, inherited ciliopathy of childhood that is caused by management of ARPKD patients should include consideration mutations in the PKHD1-gene on chromosome 6. The charac- of potential problems related to these manifestations. teristic dilatation of the renal collecting ducts starts in utero and can present at any stage from infancy to adulthood. Renal Keywords ARPKD . Extrarenal manifestation . Children . insufficiency may already begin in utero and may lead to early Hepatic fibrosis . Portal hypertension . Caroli’ssyndrome abortion or oligohydramnios and lung hypoplasia in the new- born. However, there are also affected children who have no evidence of renal dysfunction in utero and who are born with Introduction normal renal function. Up to 30 % of patients die in the perinatal period, and those surviving the neonatal period reach Autosomal recessive polycystic kidney disease (ARPKD) be- end stage renal disease (ESRD) in infancy, early childhood or longs to the family of cilia-related disorders and is an important adolescence. In contrast, some affected patients have been inherited disease with distinct clinical features and genetics.
    [Show full text]
  • Targeted Exome Sequencing Provided Comprehensive Genetic Diagnosis of Congenital Anomalies of the Kidney and Urinary Tract
    Journal of Clinical Medicine Article Targeted Exome Sequencing Provided Comprehensive Genetic Diagnosis of Congenital Anomalies of the Kidney and Urinary Tract 1,2, 3,4, 3 1,5 Yo Han Ahn y, Chung Lee y, Nayoung K. D. Kim , Eujin Park , Hee Gyung Kang 1,2,6,* , Il-Soo Ha 1,2,6, Woong-Yang Park 3,4,7 and Hae Il Cheong 1,2,6 1 Department of Pediatrics, Seoul National University College of Medicine, Seoul 03080, Korea; [email protected] (Y.H.A.); [email protected] (E.P.); [email protected] (I.-S.H.); [email protected] (H.I.C.) 2 Department of Pediatrics, Seoul National University Children’s Hospital, Seoul 03080, Korea 3 Samsung Genome Institute, Samsung Medical Center, Seoul 06351, Korea; [email protected] (C.L.); [email protected] (N.K.D.K.); [email protected] (W.-Y.P.) 4 Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul 06351, Korea 5 Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul 07441, Korea 6 Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine, Seoul 03080, Korea 7 Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon 16419, Korea * Correspondence: [email protected] These authors equally contributed to this article. y Received: 31 January 2020; Accepted: 8 March 2020; Published: 10 March 2020 Abstract: Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease in children.
    [Show full text]
  • Article Case Report Congenital Hepatic Fibrosis
    Article Case report Congenital hepatic fibrosis: case report and review of literature Brahim El Hasbaoui, Zainab Rifai, Salahiddine Saghir, Anas Ayad, Najat Lamalmi, Rachid Abilkassem, Aomar Agadr Corresponding author: Zainab Rifai, Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco. [email protected] Received: 19 Jan 2021 - Accepted: 03 Feb 2021 - Published: 18 Feb 2021 Keywords: Fibrosis, hyper-transaminasemia, cholestasis, ciliopathy, case report Copyright: Brahim El Hasbaoui et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Cite this article: Brahim El Hasbaoui et al. Congenital hepatic fibrosis: case report and review of literature. Pan African Medical Journal. 2021;38(188). 10.11604/pamj.2021.38.188.27941 Available online at: https://www.panafrican-med-journal.com//content/article/38/188/full Congenital hepatic fibrosis: case report and review &Corresponding author of literature Zainab Rifai, Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, Brahim El Hasbaoui1, Zainab Rifai2,&, Salahiddine University Mohammed V, Rabat, Morocco Saghir1, Anas Ayad1, Najat Lamalmi3, Rachid 1 1 Abilkassem , Aomar Agadr 1Department of Pediatrics, Military Teaching Hospital Mohammed V, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco, 2Department of Pediatrics, Children’s Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco, 3Department of Histopathologic, Avicenne Hospital, Faculty of Medicine and Pharmacy, University Mohammed V, Rabat, Morocco Article characterized histologically by defective Abstract remodeling of the ductal plate (DPM).
    [Show full text]
  • Management of Choledochal Cysts
    REVIEW CURRENT OPINION Management of choledochal cysts Sean M. Ronnekleiv-Kelly, Kevin C. Soares, Aslam Ejaz, and Timothy M. Pawlik Purpose of review Historically, surgical treatment of choledochal cyst consisted of cyst enterostomy. However, incomplete cyst excision can result in recurrent symptoms and malignant transformation within the cyst remnant. 09/20/2020 on BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3pxNPODIEKBpIl4WIJuUC3wZcoMyoyOwWjpQO3AzJmNqjsWy7MP1HEA== by https://journals.lww.com/co-gastroenterology from Downloaded Downloaded Accordingly, management of choledochal cyst now includes complete cyst excision whenever possible. We provide a review detailing the up to date management of choledochal cysts. We describe choledochal from cyst-type specific surgical approaches, the impact of minimally invasive surgery in choledochal cyst https://journals.lww.com/co-gastroenterology therapy, and long-term sequelae of choledochal cyst management. Recent findings Treatment of choledochal cyst aims to avoid the numerous hepatic, pancreatic, or biliary complications that may occur. More recently, minimally invasive approaches are being used for the treatment of choledochal cyst with acceptable morbidity and mortality. Moreover, long-term follow up of choledochal cyst patients after resection has demonstrated that although the risk of biliary malignancy is significantly decreased after choledochal cyst resection, these patients may remain at a slightly increased risk of biliary malignancy by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3pxNPODIEKBpIl4WIJuUC3wZcoMyoyOwWjpQO3AzJmNqjsWy7MP1HEA==
    [Show full text]
  • Massachusetts Birth Defects 2002-2003
    Massachusetts Birth Defects 2002-2003 Massachusetts Birth Defects Monitoring Program Bureau of Family Health and Nutrition Massachusetts Department of Public Health January 2008 Massachusetts Birth Defects 2002-2003 Deval L. Patrick, Governor Timothy P. Murray, Lieutenant Governor JudyAnn Bigby, MD, Secretary, Executive Office of Health and Human Services John Auerbach, Commissioner, Massachusetts Department of Public Health Sally Fogerty, Director, Bureau of Family Health and Nutrition Marlene Anderka, Director, Massachusetts Center for Birth Defects Research and Prevention Linda Casey, Administrative Director, Massachusetts Center for Birth Defects Research and Prevention Cathleen Higgins, Birth Defects Surveillance Coordinator Massachusetts Department of Public Health 617-624-5510 January 2008 Acknowledgements This report was prepared by the staff of the Massachusetts Center for Birth Defects Research and Prevention (MCBDRP) including: Marlene Anderka, Linda Baptiste, Elizabeth Bingay, Joe Burgio, Linda Casey, Xiangmei Gu, Cathleen Higgins, Angela Lin, Rebecca Lovering, and Na Wang. Data in this report have been collected through the efforts of the field staff of the MCBDRP including: Roberta Aucoin, Dorothy Cichonski, Daniel Sexton, Marie-Noel Westgate and Susan Winship. We would like to acknowledge the following individuals for their time and commitment to supporting our efforts in improving the MCBDRP. Lewis Holmes, MD, Massachusetts General Hospital Carol Louik, ScD, Slone Epidemiology Center, Boston University Allen Mitchell,
    [Show full text]
  • MCQ-PG Entrance -AGADTANTRA Maitm Ca Maaohyaot \...Mama-B
    BV(DU) COLLEGE OF AYURVED, PUNE-411043 (MH- INDIA) MCQ-PG Entrance -AGADTANTRA 1 maitM ca maaohyaot\...mama-banQaana\ iCnnait ca ÈÈ A) raOxyaat \ B) saaOxmyaat\ tOxNyaat\ AaOYNyaat C) D) 2 ivaYaM ca vaRQdyao …… A) GaRtM B) tOlaM vasaaM xaaOd`M C) D) 3. ……garsaM&M tu ik`yato ivaivaQaaOYaQaOÁ ÈÈ A) kRi~maM B) sqaavarM jaMgamaM dUiYatM C) D) 4. garo…… È A) GaRtM B) tama`M xaaOd`M homaÁ C) D) 5. ….vas~oYau Sayyaasau kvacaaBarNaoYau ca È A) pRYzoYau B) s~xau AnyaoYau padpIzoYau C) D) 6. vaIyaa-lpBaavaanna inapatyaot\ tt\ ……. vaYa-gaNaanaubainQa È A) iptavaR%tM B) vaatavaR%tM kfavaR%tM maodaovaR%tM C) D) 7. According to Sushruta, Sthavar visha adhisthana are …. in number. A) 16 B) 10 C) 8 D) 13 8. According to Sushruta, Jangam visha adhisthana are …. in number. A) 10 B) 12 C) 16 D) 14 Bharati Vidyapeeth (Deemed to be University) College of Ayurved, Pune. Tel.: 20-24373954; Email- [email protected]; Website:-www.coayurved.bharatividyapeeth.edu 9. …… is one of the ingredients of dooshivishari Agad. A) Mamsi B) Amruta C) Shunthi D) Triphala 10. Which of the following yog is used for the treatment of garopahat pawak? A) Dooshivishari B) Moorvadi C) Eladi D) Panchashirisha 11. Tobacco is……poison. A) Corrosive B) somniferous C) cardiac D) spinal 12. Which of the following is a spinal stimulant poison? A) Ahifen B) Kuchala C) Vatsanabh D) Arka 13. ivaYasaMk`maNaaqa-M mastko BaoYajadanama\ [it……… È A) ]paQaanama \ B) AirYTma\ inaYpIDnama\ pirYaokma\ C) D) 14. Which of the following dravya is not used for hrudayavaran? A) Gomay ras B) Kshaudra C) Supakwa Ekshu D) Mudgayusha 15.
    [Show full text]
  • Chapter 1 Cellular Reaction to Injury 3
    Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1).
    [Show full text]
  • 2016 Essentials of Dermatopathology Slide Library Handout Book
    2016 Essentials of Dermatopathology Slide Library Handout Book April 8-10, 2016 JW Marriott Houston Downtown Houston, TX USA CASE #01 -- SLIDE #01 Diagnosis: Nodular fasciitis Case Summary: 12 year old male with a rapidly growing temple mass. Present for 4 weeks. Nodular fasciitis is a self-limited pseudosarcomatous proliferation that may cause clinical alarm due to its rapid growth. It is most common in young adults but occurs across a wide age range. This lesion is typically 3-5 cm and composed of bland fibroblasts and myofibroblasts without significant cytologic atypia arranged in a loose storiform pattern with areas of extravasated red blood cells. Mitoses may be numerous, but atypical mitotic figures are absent. Nodular fasciitis is a benign process, and recurrence is very rare (1%). Recent work has shown that the MYH9-USP6 gene fusion is present in approximately 90% of cases, and molecular techniques to show USP6 gene rearrangement may be a helpful ancillary tool in difficult cases or on small biopsy samples. Weiss SW, Goldblum JR. Enzinger and Weiss’s Soft Tissue Tumors, 5th edition. Mosby Elsevier. 2008. Erickson-Johnson MR, Chou MM, Evers BR, Roth CW, Seys AR, Jin L, Ye Y, Lau AW, Wang X, Oliveira AM. Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest. 2011 Oct;91(10):1427-33. Amary MF, Ye H, Berisha F, Tirabosco R, Presneau N, Flanagan AM. Detection of USP6 gene rearrangement in nodular fasciitis: an important diagnostic tool. Virchows Arch. 2013 Jul;463(1):97-8. CONTRIBUTED BY KAREN FRITCHIE, MD 1 CASE #02 -- SLIDE #02 Diagnosis: Cellular fibrous histiocytoma Case Summary: 12 year old female with wrist mass.
    [Show full text]
  • CR340 DS69.Indd
    Acta Scientiae Veterinariae, 2018. 46(Suppl 1): 340. CASE REPORT ISSN 1679-9216 Pub. 340 Outbreak of Bovine Herpetic Meningoencephalomyelitis in Southern Brazil Julia Gabriela Wronski1, Bianca Santana Cecco1, Luan Cleber Henker1, Marina Paula Lorenzett1, Paulo Michel Roehe2, Fernando Finoketti2, Thaís Moreira Totti2 & Luciana Sonne1 ABSTRACT Background: Herpetic meningoencephalitis is an infectious contagious disease worldwide distributed, most often caused by bovine alphaherpesvirus type 5 (BoHV-5), although bovine alphaherpesvirus type 1 (BoHV-1) may occasionally be the causative agent. The disease is characterized by subacute to acute clinical onset, often affecting animals submitted to stressful situations. Clinical signs are mainly neurologic due to meningoencephalitis and cortical necrosis. The involve- ment of the spinal cord has also been reported, however in BoHV-1 associated disease only. The aim of this report is to describe an outbreak of bovine meningoencephalomyelitis associated to BoHV-5. Case: In August 2017, nine 1-year-old calves died in a beef cattle farm with a flock of approximately 400 bovines. The animals presented neurological clinical signs characterized by excessive salivation, nasal and ocular discharges, incoor- dination, apathy, head tremors, head pressing, wide-based stance, recumbency followed by convulsions and paddling. According to the owner and referring veterinarian, affected animals displayed severe clinical signs with rapid progression and often leading to death in up to seven days. Four of these
    [Show full text]